Literature DB >> 22190298

Bladder dysfunction in peripheral neuropathies.

Ahmet Z Burakgazi1, Bander Alsowaity, Zeynep Aydin Burakgazi, Dogan Unal, John J Kelly.   

Abstract

Normal bladder function depends on the complex interaction of sensory and motor pathways. Bladder dysfunction can develop as a result of several neurological conditions. It can happen in a number of ways, including diabetic cystopathy, detrusor overactivity, bladder outlet obstruction, and urge and stress urinary incontinence. Diabetic neuropathy is the most common cause of peripheral neuropathy-associated bladder dysfunction. Guillain-Barré syndrome (GBS), human immunodeficiency virus (HIV)-associated neuropathy, chronic inflammatory demyelinating polyneuropathy (CIDP), and amyloid neuropathy are other major causes. The diagnosis of bladder dysfunction should be established by the history of neurological symptoms, neurological examination, and urological evaluation. Functional evaluation of the lower urinary tract includes cystometry, sphincter electromyography, uroflowmetry, and urethral pressure profilometry. Management of urinary symptoms in patients with bladder dysfunction is usually supportive. In some cases, alpha-blocker and/or anti-muscarinic agents are needed to help improve urinary dysfunction. Intermittent self-catheterization is needed occasionally for patients with slow and/or poor recovery.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22190298     DOI: 10.1002/mus.22178

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  12 in total

Review 1.  Neurogenic lower urinary tract dysfunction: evaluation and management.

Authors:  Katarina Ivana Tudor; Ryuji Sakakibara; Jalesh N Panicker
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

Review 2.  Voiding dysfunction due to detrusor underactivity: an overview.

Authors:  Marcus J Drake; Jonathan Williams; Dominika A Bijos
Journal:  Nat Rev Urol       Date:  2014-07-08       Impact factor: 14.432

3.  Spinal blockage of P/Q- or N-type voltage-gated calcium channels modulates functional and symptomatic changes related to haemorrhagic cystitis in mice.

Authors:  R B M Silva; N D M Sperotto; E L Andrade; T C B Pereira; C E Leite; A H de Souza; M R Bogo; F B Morrone; M V Gomez; M M Campos
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

Review 4.  Potential role of oxidative stress in the pathogenesis of diabetic bladder dysfunction.

Authors:  Qi-Xiang Song; Yi Sun; Kangli Deng; Jin-Yi Mei; Christopher J Chermansky; Margot S Damaser
Journal:  Nat Rev Urol       Date:  2022-08-16       Impact factor: 16.430

5.  Management of Stress Urinary Incontinence With Pelvic Floor Muscle Training for a Woman With Charcot-Marie-Tooth Disease: A Case Report.

Authors:  Letícia A Ferreira; Fátima F Fitz; Márcia M Gimenez; Mayanni M P Matias; Maria A T Bortolini; Rodrigo A Castro
Journal:  J Chiropr Med       Date:  2022-06-06

Review 6.  Vaginal childbirth and pelvic floor disorders.

Authors:  Hafsa U Memon; Victoria L Handa
Journal:  Womens Health (Lond)       Date:  2013-05

7.  CGRP protects bladder smooth muscle cells stimulated by high glucose through inhibiting p38 MAPK pathway in vitro.

Authors:  Jun Xue; Yadong Liu; Sichong Zhang; Liucheng Ding; Baixin Shen; Yunpeng Shao; Zhongqing Wei
Journal:  Sci Rep       Date:  2021-04-07       Impact factor: 4.379

Review 8.  Current View of Diagnosing Small Fiber Neuropathy.

Authors:  Lisette R M Raasing; Oscar J M Vogels; Marcel Veltkamp; Christiaan F P van Swol; Jan C Grutters
Journal:  J Neuromuscul Dis       Date:  2021

Review 9.  Strategies to improve the quality of life in patients with hereditary transthyretin amyloidosis (hATTR) and autonomic neuropathy.

Authors:  Thierry Gendre; Violaine Planté-Bordeneuve
Journal:  Clin Auton Res       Date:  2019-09-10       Impact factor: 4.435

10.  CGRP Reduces Apoptosis of DRG Cells Induced by High-Glucose Oxidative Stress Injury through PI3K/AKT Induction of Heme Oxygenase-1 and Nrf-2 Expression.

Authors:  YaDong Liu; SiCong Zhang; Jun Xue; ZhongQing Wei; Ping Ao; BaiXin Shen; LiuCheng Ding
Journal:  Oxid Med Cell Longev       Date:  2019-11-25       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.